TY - JOUR
T1 - Coronary circulatory function with increasing obesity
T2 - A complex U-turn
AU - Upadhyaya, Anand
AU - Bhandiwad, Anita
AU - Lang, Jordan
AU - Sadhu, Justin S.
AU - Barrs, Chadwick
AU - Jain, Sudhir
AU - Brown, David
AU - Peterson, Linda
AU - Dehdashti, Farrokh
AU - Gropler, Robert J.
AU - Schindler, Thomas Hellmuth
N1 - Funding Information:
This study was supported by a departmental fund from Washington University in St. Louis.
Publisher Copyright:
© 2022 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
PY - 2022/6
Y1 - 2022/6
N2 - Aims: The aim of this investigation was to explore and characterize alterations in coronary circulatory function in function of increasing body weight with medically controlled cardiovascular risk factors and, thus, “metabolically” unhealthy obesity. Materials and Methods: We prospectively enrolled 106 patients with suspected CAD but with normal stress-rest myocardial perfusion on 13N-ammonia PET/CT and with medically controlled or no cardiovascular risk factors. 13N-ammonia PET/CT concurrently determined myocardial blood flow (MBF) during pharmacologically induced hyperaemia and at rest. Based on body mass index (BMI), patients were grouped into normal weight (BMI: 20.0–24.9 kg/m2, n = 22), overweight (BMI: 25.0–29.9 kg/m2, n = 27), obese (BMI: 30.0–39.9 kg/m2, n = 31), and morbidly obese (BMI ≥ 40kg/m2, n = 26). Results: Resting MBF was comparable among groups (1.09 ± 0.18 vs. 1.00 ± 0.15 vs. 0.96 ± 0.18 vs. 1.06 ± 0.31 ml/g/min; p =.279 by ANOVA). Compared to normal weight individuals, the hyperaemic MBF progressively decreased in in overweight and obese groups, respectively (2.54 ± 0.48 vs. 2.02 ± 0.27 and 1.75 ± 0.39 ml/g/min; p <.0001), while it increased again in the group of morbidly obese individuals comparable to normal weight (2.44 ± 0.41 vs. 2.54 ± 0.48 ml/g/min, p =.192). The BMI of the study population correlated with the hyperaemic MBF in a quadratic or U-turn fashion (r =.34, SEE = 0.46; p ≤.002). Conclusions: The U-turn of hyperaemic MBF from obesity to morbid obesity is likely to reflect contrasting effects of abdominal versus subcutaneous adipose tissue on coronary circulatory function indicative of two different disease entities, but needing further investigations.
AB - Aims: The aim of this investigation was to explore and characterize alterations in coronary circulatory function in function of increasing body weight with medically controlled cardiovascular risk factors and, thus, “metabolically” unhealthy obesity. Materials and Methods: We prospectively enrolled 106 patients with suspected CAD but with normal stress-rest myocardial perfusion on 13N-ammonia PET/CT and with medically controlled or no cardiovascular risk factors. 13N-ammonia PET/CT concurrently determined myocardial blood flow (MBF) during pharmacologically induced hyperaemia and at rest. Based on body mass index (BMI), patients were grouped into normal weight (BMI: 20.0–24.9 kg/m2, n = 22), overweight (BMI: 25.0–29.9 kg/m2, n = 27), obese (BMI: 30.0–39.9 kg/m2, n = 31), and morbidly obese (BMI ≥ 40kg/m2, n = 26). Results: Resting MBF was comparable among groups (1.09 ± 0.18 vs. 1.00 ± 0.15 vs. 0.96 ± 0.18 vs. 1.06 ± 0.31 ml/g/min; p =.279 by ANOVA). Compared to normal weight individuals, the hyperaemic MBF progressively decreased in in overweight and obese groups, respectively (2.54 ± 0.48 vs. 2.02 ± 0.27 and 1.75 ± 0.39 ml/g/min; p <.0001), while it increased again in the group of morbidly obese individuals comparable to normal weight (2.44 ± 0.41 vs. 2.54 ± 0.48 ml/g/min, p =.192). The BMI of the study population correlated with the hyperaemic MBF in a quadratic or U-turn fashion (r =.34, SEE = 0.46; p ≤.002). Conclusions: The U-turn of hyperaemic MBF from obesity to morbid obesity is likely to reflect contrasting effects of abdominal versus subcutaneous adipose tissue on coronary circulatory function indicative of two different disease entities, but needing further investigations.
KW - adipocytokines
KW - body weight
KW - coronary circulation
KW - morbid obesity
KW - myocardial blood flow
KW - myocardial flow reserve
KW - obesity
KW - positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=85124475343&partnerID=8YFLogxK
U2 - 10.1111/eci.13755
DO - 10.1111/eci.13755
M3 - Article
C2 - 35103996
AN - SCOPUS:85124475343
SN - 0014-2972
VL - 52
JO - European Journal of Clinical Investigation
JF - European Journal of Clinical Investigation
IS - 6
M1 - e13755
ER -